We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

16 hedge funds and large institutions have $1.43M invested in Aethlon Medical in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

75% more capital invested

Capital invested by funds: $816K → $1.43M (+$611K)

45% more funds holding

Funds holding: 11 → 16 (+5)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
16
Holders Change
+5
Holders Change %
+45.45%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$741K
2
VF
Virtu Financial
New York
+$48.1K
3
Citadel Advisors
Citadel Advisors
Florida
+$38.5K
4
FMBTD
First Midwest Bank Trust Division
Illinois
+$38.5K
5
Millennium Management
Millennium Management
New York
+$38.5K

Top Sellers

Rank Fund Capital Flow
1
SSA
Schonfeld Strategic Advisors
New York
-$41K
2
SPC
Sigma Planning Corp
Michigan
-$28K

AEMD Hedge Fund Activity: Q1 2021 in Review

16 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2021, worth a combined $1.43M — up 75% from $816K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AEMD positions and 2 closed out — a net gain of 5 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $741K. The largest seller was Schonfeld Strategic Advisors, exiting entirely with an estimated $41K sold.

  • 16 institutional investors held Aethlon Medical (AEMD) as of Q1 2021, up from 11 in Q4 2020.
  • Funds reported $1.43M of Aethlon Medical stock for Q1 2021, up 75% quarter-over-quarter.
  • 7 funds opened new Aethlon Medical positions in Q1 2021 and 2 closed out, a net change of +5 holders.
  • The largest Aethlon Medical buyer in Q1 2021 was Renaissance Technologies, an estimated $741K added.
  • The largest Aethlon Medical seller in Q1 2021 was Schonfeld Strategic Advisors, an estimated $41K sold.

Based on aggregated 13F filings for Q1 2021.